RHOA, ras homolog family member A, 387

N. diseases: 193; N. variants: 16
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007115
Disease: Malignant neoplasm of thyroid
Malignant neoplasm of thyroid
0.010 Biomarker disease BEFREE Our present findings expounded a novel signal cascade employing miR-154-3p/487-3p and RHOA to fine-tune thyroid cancer cell proliferation and apoptosis. 31820783 2020
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.010 Biomarker disease BEFREE Our present findings expounded a novel signal cascade employing miR-154-3p/487-3p and RHOA to fine-tune thyroid cancer cell proliferation and apoptosis. 31820783 2020
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.010 Biomarker disease BEFREE Our present findings expounded a novel signal cascade employing miR-154-3p/487-3p and RHOA to fine-tune thyroid cancer cell proliferation and apoptosis. 31820783 2020
CUI: C0004245
Disease: Atrioventricular Block
Atrioventricular Block
0.010 Biomarker disease BEFREE Disruption of RHOA-ROCK Signaling Results in Atrioventricular Block and Disturbed Development of the Putative Atrioventricular Node. 30412368 2019
CUI: C0007192
Disease: Cardiomyopathy, Alcoholic
Cardiomyopathy, Alcoholic
0.010 AlteredExpression disease BEFREE Administration of valsartan reversed the expression profile of RhoA, ROCK and MYL in ACM. 31777538 2019
CUI: C0014836
Disease: Escherichia coli Infections
Escherichia coli Infections
0.010 Biomarker group BEFREE Pathway enrichment analysis showed that down-regulated Ras homolog gene family member A (RHOA) was enriched in pathogenic Escherichia coli infection. 30155678 2019
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 AlteredExpression disease BEFREE Expression of RhoA and ROCK were elevated with downregulation of MYL resulting in heart failure. 31777538 2019
CUI: C0019163
Disease: Hepatitis B
Hepatitis B
0.010 Biomarker disease BEFREE Additionally, SMAD2, EGFR, AKT1, RHOA and GAS5 might be associated with the curative effect of HQDG on hepatitis B cirrhosis patients. 30155678 2019
CUI: C0020541
Disease: Portal Hypertension
Portal Hypertension
0.010 Biomarker disease BEFREE MiR-26b mimics played a role in the treatment of rats with cirrhotic portal hypertension by targeting hENT1 to inhibit the RhoA/ROCK-1 signaling pathway. 30840291 2019
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.010 Biomarker disease BEFREE However, a few in vivo experiments have been successfully conducted to demonstrate the potential value of RhoA/ROCK pathway inhibition in the treatment of OA. 31632513 2019
CUI: C0155877
Disease: Allergic asthma
Allergic asthma
0.010 AlteredExpression disease BEFREE Both SHP2 and Ras homolog family member A (RhoA) kinase were robustly activated in the airway eosinophils of children with allergic asthma and of a mouse model with allergic airway inflammation. 31361966 2019
CUI: C0264886
Disease: Conduction disorder of the heart
Conduction disorder of the heart
0.010 AlteredExpression group BEFREE RHOA is expressed in the atrioventricular node (AVN) and altered expression of RHOA results in atrioventricular (AV) conduction disorders in mice. 30412368 2019
Amputated structure (morphologic abnormality)
0.010 AlteredExpression phenotype BEFREE In the model of gecko tail amputation, the protein levels of gecko MIF (gMIF) have been determined to be significantly increased in the nerve cells of the spinal cord in association with the recruitment of macrophages to the lesion site. gMIF has been shown to interact with the CD74 receptor to promote the migration of macrophages through activation of Ras homolog gene family member A and to trigger inflammatory responses through MAPK signaling pathways. 31689136 2019
CUI: C0334279
Disease: Adenocarcinoma, intestinal type
Adenocarcinoma, intestinal type
0.010 GeneticVariation disease BEFREE The present study showed that intestinal-type adenocarcinoma with anastomosing glands represents a genetically distinct group of tumors with the frequent presence of RHOA mutations and CLDN18-ARHGAP fusions, which are thought to be specific to diffuse-type gastric cancers. 30425335 2019
Secondary malignant neoplasm of liver
0.010 AlteredExpression disease BEFREE Mechanistically, SNS-032 repressed the c-Myc-dependent transcription of RhoA gene, and thereby lowered the RhoA GTPase activity and actin polymerization, and subsequently inhibited cell motility and liver metastasis. 31526394 2019
CUI: C1332206
Disease: Adult Lymphoma
Adult Lymphoma
0.010 GeneticVariation disease BEFREE The test evaluates the expression of 20 genes, including 17 markers relevant to T-cell immunology and lymphoma biopathology, one EBV-related transcript, and variants of RHOA (G17V) and IDH2 (R172K/T). 31488561 2019
CUI: C1332979
Disease: Childhood Lymphoma
Childhood Lymphoma
0.010 GeneticVariation disease BEFREE The test evaluates the expression of 20 genes, including 17 markers relevant to T-cell immunology and lymphoma biopathology, one EBV-related transcript, and variants of RHOA (G17V) and IDH2 (R172K/T). 31488561 2019
Malformations of Cortical Development, Group II
0.010 AlteredExpression disease BEFREE Restoration of the RhoA protein level partially rescued the neuronal migration defects in the GR-knockdown and GR-overexpressing neurons, indicating that RhoA played a major role in GR-mediated neuronal migration. 31176306 2019
ALBINOIDISM, OCULOCUTANEOUS, AUTOSOMAL DOMINANT
0.010 GeneticVariation disease BEFREE Here we show that postzygotic inactivating mutations of RHOA cause a neuroectodermal syndrome combining linear hypopigmentation, alopecia, apparently asymptomatic leukoencephalopathy, and facial, ocular, dental and acral anomalies. 31570889 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.010 Biomarker disease BEFREE Cell division control protein 42 homolog (CDC42) and Ras homolog gene family member A (RhoA) were the therapy targets of YQYYHTQY recipe on T2DM. 29654829 2018
CUI: C0014070
Disease: Encephalomyelitis
Encephalomyelitis
0.010 GeneticVariation disease BEFREE Using mice with a T-cell specific deletion of the RhoA gene (RhoA<sup>fl/fl</sup>LckCre<sup>+</sup>), we investigated the role of RhoA in T-cell development, functionality, and encephalitogenic potential in EAE. 29904389 2018
CUI: C0015934
Disease: Fetal Growth Retardation
Fetal Growth Retardation
0.010 AlteredExpression phenotype BEFREE Compared with the control group, the mRNA and protein levels of RhoA and ROCK2 were higher in the FGR group but lower in the Taurine group (p < .05). 28412885 2018
CUI: C0027092
Disease: Myopia
Myopia
0.010 Biomarker disease BEFREE These findings provided evidence for a mechanical strain-induced RhoA/ROCK2 pathway that may contribute to myopia scleral remodeling. 30029249 2018
CUI: C0035412
Disease: Rhabdomyosarcoma
Rhabdomyosarcoma
0.010 Biomarker disease BEFREE Expression of constitutively active and dominant-negative isoforms of RHOA revealed that it acts downstream of VANGL2 to regulate proliferation and maintenance of TPCs in human RMS. 29499154 2018
Secondary malignant neoplasm of lung
0.010 Biomarker disease BEFREE Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis. 29580806 2018